UNSPSC 85446001: The diagnosis of oxytocic drugs

In this classification, this covers the group of activities that yields a diagnosis of oxytocic drugs. Oxytocic drugs is listed In The World Health Organization's International Statistical Classification of Diseases and Related Health Problems (ICD-10) as a four-character category under code Y55.0.

UNSPSC 85446001 "Diagnosis of oxytocic drugs" is a Commodity code with a significant mismatch between its nominal scope and recent state and local procurement activity. The three most recent opportunities tagged to this code involve diagnostic imaging PACS system procurement, special education contracted services (audiologists, speech therapists, occupational therapists, and related specialists), and temporary health professional staffing in ancillary clinical categories — none of which concern oxytocic pharmaceuticals or their diagnosis. State and local governments do not appear to be buying under this code's actual scope at present; the tagging appears to reflect data-quality issues rather than genuine procurement demand for oxytocin-related diagnostic services.

The recent opportunities show activity from a county health system (San Mateo Medical Center in California), an independent school district (Birdville ISD in Texas), and another county health system (Santa Clara Health System in California), but these solicitations do not align with the code's stated purpose. The San Mateo and Santa Clara opportunities, posted in July and October 2026 with response dates in October 2026, concern diagnostic imaging infrastructure and temporary clinical staffing rather than pharmaceutical diagnostics. A business development professional evaluating this code should recognize that the current tagging does not reflect genuine procurement under UNSPSC 85446001 and should seek clarification on whether the code taxonomy itself or the opportunity-tagging process contains errors.